Physician profile
Marc A Neff
NPI 1639170137
$7,363.83
in general payments reported to CMS, 2019-2025
9 companies · $132 in 2025
The $132 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $348 · 2021: $595 · 2022: $5,904 · 2023: $260 · 2024: $125 · 2025: $132.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $517.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $517.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,260.22 | 2021-2025 | |
| Novo Nordisk INC | $625.62 | 2019-2024 | Wegovy |
| Davol INC. | $117.72 | 2019 | |
| Baxter Healthcare | $114.31 | 2019 | |
| Innocoll Pharmaceuticals Limited | $93.95 | 2021 | |
| Intra-Sana Laboratories | $50.00 | 2023 | Reltone 400 Mg, Reltone 200 Mg |
| Medical Device Business Services, INC. | $45.86 | 2023 | |
| Smith+Nephew, INC. | $31.92 | 2019-2021 | |
| Ethicon US, LLC | $24.23 | 2025 | Enseal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Neff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.